Zacks Investment Research
25 May 2026, 14:56 UTC · 25w ago
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Impact · against what's priced in
Carlsmed (CARL) shows positive momentum backed by upward earnings revisions and a strong analyst consensus price target of $18.40. These factors suggest fundamental operational improvements that may not be fully reflected in the current $12.11 share price.
- CARL+0.60
No priced-in read yet





